<dl class="row">
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Al-Babtain B, Cheema E, Hadi MA. Impact of community-pharmacist-led medication review programmes on patient outcomes: A systematic review and meta-analysis of randomised controlled trials. Res Social Adm Pharm. 2021 Apr 29:S1551-7411(21)00163-7. doi: 10.1016/j.sapharm.2021.04.022. Epub ahead of print. PMID: 33965357. 
  </ref>
  <a><pmid>PMID33965357   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sud D, Laughton E, McAskill R, Bradley E, Maidment I. The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review. Syst Rev. 2021 Mar 31;10(1):92. doi: 10.1186/s13643-021-01586-9. PMID: 33789745; PMCID: PMC8015120. 
  </ref>
  <a><pmid>PMID33789745   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Desse TA, Vakil K, Mc Namara K, Manias E. Impact of clinical pharmacy interventions on health and economic outcomes in type 2 diabetes: A systematic review and meta-analysis. Diabet Med. 2021 Jun;38(6):e14526. doi: 10.1111/dme.14526. Epub 2021 Mar 14. PMID: 33470480. 
  </ref>
  <a><pmid>PMID33470480   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gurwitz JH, Kapoor A, Garber L, Mazor KM, Wagner J, Cutrona SL, Singh S, Kanaan AO, Donovan JL, Crawford S, Anzuoni K, Konola TJ, Zhou Y, Field TS. Effect of a Multifaceted Clinical Pharmacist Intervention on Medication Safety After Hospitalization in Persons Prescribed High-risk Medications: A Randomized Clinical Trial. JAMA Intern Med. 2021 May 1;181(5):610-618. doi: 10.1001/jamainternmed.2020.9285. Erratum in: doi: 10.1001/jamainternmed.2021.2050. PMID: 33646267; PMCID: PMC7922235. 
  </ref>
  <a><pmid>PMID33646267   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Al Hamarneh YN, Marra C, Gniadecki R, Keeling S, Morgan A, Tsuyuki R. RxIALTA: evaluating the effect of a pharmacist-led intervention on CV risk in patients with chronic inflammatory diseases in a community pharmacy setting: a prospective pre-post intervention study. BMJ Open. 2021 Mar 24;11(3):e043612. doi: 10.1136/bmjopen-2020-043612. PMID: 33762234; PMCID: PMC7993291. 
  </ref>
  <a><pmid>PMID33762234   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Zhang Y, Yang H, Kong J, Liu L, Ran L, Zhang X, Yun J, Gu Q. Impact of interventions targeting the inappropriate use of proton-pump inhibitors by clinical pharmacists in a hepatobiliary surgery department. J Clin Pharm Ther. 2021 Feb;46(1):149-157. doi: 10.1111/jcpt.13273. Epub 2020 Oct 5. PMID: 33015848. 
  </ref>
  <a><pmid>PMID33015848   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gautier JF, Boitard C, Michiels Y, Raymond G, Vergez G, Guedon G. Impact of personalized text messages from pharmacists on medication adherence in type 2 diabetes in France: A real-world, randomized, comparative study. Patient Educ Couns. 2021 Feb 13:S0738-3991(21)00120-8. doi: 10.1016/j.pec.2021.02.022. Epub ahead of print. PMID: 33750593. 
  </ref>
  <a><pmid>PMID33750593   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hurst H, Dunn S, Fuji KT, Gilmore J, Wilt S, Webster S, Parikh P. Clinical impact of a pharmacist + health coach chronic disease management program in a rural free clinic. J Am Pharm Assoc (2003). 2021 Jul-Aug;61(4):442-449. doi: 10.1016/j.japh.2021.02.014. Epub 2021 Feb 27. PMID: 33775539. 
  </ref>
  <a><pmid>PMID33775539   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rea K, Jadallah J, Nadpara P, Goode JK. Evaluation of the impact of a community-based, pharmacist-led weight loss program focused on a high-protein diet on risk factors for cardiovascular disease. J Am Pharm Assoc (2003). 2021 Jul-Aug;61(4S):S147-S153. doi: 10.1016/j.japh.2021.01.027. Epub 2021 Feb 20. PMID: 33618987. 
  </ref>
  <a><pmid>PMID33618987   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lloyd M, Bennett N, Wilkinson A, Furlong N, Cardwell J, Michaels S. A mixed-methods evaluation of the impact of a pharmacist-led feedback pilot intervention on insulin prescribing in a hospital setting. Res Social Adm Pharm. 2021 Mar 13:S1551-7411(21)00113-3. doi: 10.1016/j.sapharm.2021.03.007. Epub ahead of print. PMID: 33775557. 
  </ref>
  <a><pmid>PMID33775557   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ray S, Lokken J, Whyte C, Baumann A, Oldani M. The impact of a pharmacist-driven, collaborative practice on diabetes management in an Urban underserved population: a mixed method assessment. J Interprof Care. 2020;34(1):27-35. doi:10.1080/13561820.2019.1633289 
  </ref>
  <a><pmid>PMID31381470   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Abdulrhim S, Sankaralingam S, Ibrahim MIM, Awaisu A. The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviews [published online ahead of print, 2020 Jan 8]. Prim Care Diabetes. 2020;S1751-9918(19)30425-5. doi:10.1016/j.pcd.2019.12.007 
  </ref>
  <a><pmid>PMID31926868   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Qin SB, Zhang XY, Fu Y, et al. The impact of the clinical pharmacist-led interventions in China: A systematic review and Meta-Analysis. Int J Clin Pharm. 2020;42(2):366-377. doi:10.1007/s11096-020-00972-y 
  </ref>
  <a><pmid>PMID32078109   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Nogueira M, Otuyama LJ, Rocha PA, Pinto VB. Pharmaceutical care-based interventions in type 2 diabetes mellitus : a systematic review and meta-analysis of randomized clinical trials. Einstein (Sao Paulo). 2020;18:eRW4686. Published 2020 Jan 31. doi:10.31744/einstein_journal/2020RW4686 
  </ref>
  <a><pmid>PMID32022107   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Newman TV, San-Juan-Rodriguez A, Parekh N, et al. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: An umbrella review [published online ahead of print, 2020 Jan 14]. Res Social Adm Pharm. 2020;S1551-7411(19)30553-4. doi:10.1016/j.sapharm.2019.12.016 
  </ref>
  <a><pmid>PMID31959565   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sherrill CH, Houpt CT, Dixon EM, Richter SJ. Effect of Pharmacist-Driven Professional Continuous Glucose Monitoring in Adults with Uncontrolled Diabetes. J Manag Care Spec Pharm. 2020;26(5):600-609. doi:10.18553/jmcp.2020.26.5.600 
  </ref>
  <a><pmid>PMID32347180   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pousinho S, Morgado M, Plácido AI, Roque F, Falcão A, Alves G. Clinical pharmacists´ interventions in the management of type 2 diabetes mellitus: a systematic review. Pharm Pract (Granada). 2020 Jul-Sep;18(3):2000. doi: 10.18549/PharmPract.2020.3.2000. Epub 2020 Aug 28. PMID: 32922572; PMCID: PMC7470242. 
  </ref>
  <a><pmid>PMID32922572   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Frederick A, Juan J, Ivy D, Maldonado YM. Effect of Visit Frequency of Pharmacist-Led Diabetes Medication Management Program. J Pharm Pract. 2020 Aug 24:897190020948685. doi: 10.1177/0897190020948685. Epub ahead of print. PMID: 32830604. 
  </ref>
  <a><pmid>PMID32830604   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lakey H, Boehmer K, Johnson C. Impact of a Pharmacist-Led Group Diabetes Class. J Pharm Pract. 2020 Aug 12:897190020948678. doi: 10.1177/0897190020948678. Epub ahead of print. PMID: 32783491. 
  </ref>
  <a><pmid>PMID32783491   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Norton MC, Haftman ME, Buzzard LN. Impact of Physician-Pharmacist Collaboration on Diabetes Outcomes and Health Care Use. J Am Board Fam Med. 2020 Sep-Oct;33(5):745-753. doi: 10.3122/jabfm.2020.05.200044. PMID: 32989069. 
  </ref>
  <a><pmid>PMID32989069   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Page A, Harrison A, Nadpara P, Goode JR. Pharmacist impact on pneumococcal polysaccharide vaccination rates in patients with diabetes in a national grocery chain pharmacy. J Am Pharm Assoc (2003). 2020 May-Jun;60(3S):S51-S55.e1. doi: 10.1016/j.japh.2020.02.007. Epub 2020 Mar 17. PMID: 32192948. 
  </ref>
  <a><pmid>PMID32192948   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chong MT. Pharmacist Interventions in Improving Clinical Outcomes in Patients with Type 2 Diabetes Mellitus Among the Underrepresented Population: A Collaborative Ambulatory Care Pharmacy Practice (CAPP) Approach. J Res Pharm Pract. 2020 Mar 28;9(1):3-9. doi: 10.4103/jrpp.JRPP_19_75. PMID: 32489954; PMCID: PMC7235450. 
  </ref>
  <a><pmid>PMID32489954   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bingham J, Silva-Almodóvar A, Lee H, Benson C, Michael R, Azurin CM, Taylor AM. The role of the pharmacist in mental health: An investigation of the impact of pharmacist-led interventions on psychotropic medication adherence in patients with diabetes. J Am Pharm Assoc (2003). 2020 Jul-Aug;60(4):e58-e63. doi: 10.1016/j.japh.2020.01.009. Epub 2020 Feb 26. PMID: 32113946. 
  </ref>
  <a><pmid>PMID32113946   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     La Regina R, Pandolfi D, Stabile N, Beloni L, Glisenti F, Griggio P, La Regina M, La Regina G. A New Case Manager for Diabetic Patients: A Pilot Observational Study of the Role of Community Pharmacists and Pharmacy Services in the Case Management of Diabetic Patients. Pharmacy (Basel). 2020 Oct 19;8(4):193. doi: 10.3390/pharmacy8040193. PMID: 33086680; PMCID: PMC7712646. 
  </ref>
  <a><pmid>PMID33086680   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Besemah NA, Sartika RAD, Sauriasari R. Effect of Pharmacist Intervention on Medication Adherence and Clinical Outcomes of Type 2 Diabetes Mellitus Outpatients in Primary Healthcare in Indonesia. J Res Pharm Pract. 2021 Jan 11;9(4):186-195. doi: 10.4103/jrpp.JRPP_20_59. PMID: 33912501; PMCID: PMC8067894. 
  </ref>
  <a><pmid>PMID33520795   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Alsuwayni B, Alhossan A. Impact of clinical pharmacist-led diabetes management clinic on health outcomes at an academic hospital in Riyadh, Saudi Arabia: A prospective cohort study. Saudi Pharm J. 2020 Dec;28(12):1756-1759. doi: 10.1016/j.jsps.2020.11.002. Epub 2020 Nov 11. PMID: 33424266; PMCID: PMC7783205. 
  </ref>
  <a><pmid>PMID33424266   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     McFarland MS, Thomas AM, Young E, Bryant C, Hughes JC, Hoffman J, Baker JW. Implementation and Effect of a Pharmacist-to-Pharmacist Transitions of Care Initiative on Ambulatory Care Sensitive Conditions. J Manag Care Spec Pharm. 2020 Apr;26(4):513-519. doi: 10.18553/jmcp.2020.26.4.513. PMID: 32223605. 
  </ref>
  <a><pmid>PMID32223605   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Watkins VA, Michaels NM, Jackson DL, Rhodes LA, Marciniak MW. The effect of community pharmacist-led health coaching on clinical outcomes. J Am Pharm Assoc (2003). 2020 May-Jun;60(3S):S65-S69. doi: 10.1016/j.japh.2020.03.021. Epub 2020 May 18. PMID: 32439280. 
  </ref>
  <a><pmid>PMID32439280   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hernández-Muñoz JJ, De Santiago AC, Cedrone SZ, Verduzco RA, Bazan DZ. Impact of Pharmacist-Led Drug Therapy Management Services on HbA1c Values in a Predominantly Hispanic Population Visiting an Outpatient Endocrinology Clinic. J Pharm Pract. 2020 Jun 4:897190020927863. doi: 10.1177/0897190020927863. Epub ahead of print. PMID: 32495714. 
  </ref>
  <a><pmid>PMID32495714   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Upadhyay DK, Mohamed Ibrahim MI, Mishra P, Alurkar VM. Impact assessment of pharmacist-supervised intervention on health-related quality of life of newly diagnosed diabetics: A pre-post design. J Pharm Bioallied Sci. 2020 Jul-Sep;12(3):234-245. doi: 10.4103/jpbs.JPBS_6_20. Epub 2020 Jul 18. PMID: 33100782; PMCID: PMC7574756. 
  </ref>
  <a><pmid>PMID33100782   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Johnson K, Kirby J, Kayse A, Brookhart A, Frede S, Hincapie A. Impact of an adherence intervention program on patient adherence and star ratings measures in a large community pharmacy chain. J Am Pharm Assoc (2003). 2020 Jul-Aug;60(4):e70-e78. doi: 10.1016/j.japh.2020.02.017. Epub 2020 Mar 27. PMID: 32229088. 
  </ref>
  <a><pmid>PMID32229088   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Higgins KL, Hauck FR, Tanabe K, Tingen J. Role of the Ambulatory Care Clinical
Pharmacist in Management of a Refugee Patient Population at a University-Based
Refugee Healthcare Clinic. J Immigr Minor Health. 2019 Mar 20. doi:
10.1007/s10903-019-00879-5. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID30895417   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Syarifuddin S, Nasution A, Dalimunthe A, Khairunnisa. Impact of Pharmacist
Intervention on Improving the Quality of Life of Patients with Type 2 Diabetes
Mellitus. Open Access Maced J Med Sci. 2019 Apr 29;7(8):1401-1405. doi:
10.3889/oamjms.2019.140. eCollection 2019 Apr 30. 
  </ref>
  <a><pmid>PMID31110593   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bahrami S, Chang C, Alvarez KS, Lutek K, Nguyen S, Hegde A. Pharmacist impact on health outcomes in a homeless population. J Am Pharm Assoc (2003). 2020;60(3):485-490. doi:10.1016/j.japh.2019.11.013 
  </ref>
  <a><pmid>PMID31901441   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lauffenburger JC, Ghazinouri R, Jan S, et al. Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: The ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trial. PLoS One. 2019;14(4):e0214754. Published 2019 Apr 2. doi:10.1371/journal.pone.0214754 
  </ref>
  <a><pmid>PMID30939143   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lin CH, Tran NT, Muradian IK, et al. Impact of a Pharmacist-Led Diabetes Clinic in a Correctional Setting [published online ahead of print, 2019 Nov 19]. J Pharm Pract. 2019;897190019888075. doi:10.1177/0897190019888075 
  </ref>
  <a><pmid>PMID31742483   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Catic T, Jusufovic R, Horozic D, Lekic L, Tabakovic V. Pharmacists' Attitudes and Role in Diabetes Management in Bosnia and Herzegovina. Med Arch. 2019;73(5):351-355. doi:10.5455/medarh.2019.73.351-355 
  </ref>
  <a><pmid>PMID31819310   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Schmidt K, Caudill JA, Hamilton T. Impact of clinical pharmacy specialists on glycemic control in veterans with type 2 diabetes. Am J Health Syst Pharm. 2019;76(Supplement_1):S9-S14. doi:10.1093/ajhp/zxy015 
  </ref>
  <a><pmid>PMID30753315   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Alshehri AA, Jalal Z, Cheema E, Haque MS, Jenkins D, Yahyouche A. Impact of the pharmacist-led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: A systematic review and meta-analysis of randomised controlled trials. Br J Clin Pharmacol. 2020;86(1):29-38. doi:10.1111/bcp.14164 
  </ref>
  <a><pmid>PMID31777082   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Iqbal MZ, Khan AH, Iqbal MS, Syed Sulaiman SA. A Review of Pharmacist-led Interventions on Diabetes Outcomes: An Observational Analysis to Explore Diabetes Care Opportunities for Pharmacists. J Pharm Bioallied Sci. 2019;11(4):299-309. doi:10.4103/jpbs.JPBS_138_19 
  </ref>
  <a><pmid>PMID31619911   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Presley B, Groot W, Pavlova M. Pharmacy-led interventions to improve medication adherence among adults with diabetes: A systematic review and meta-analysis. Res Social Adm Pharm. 2019;15(9):1057-1067. doi:10.1016/j.sapharm.2018.09.021 
  </ref>
  <a><pmid>PMID30685443   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hening WN, Sartika RAD, Sauriasari R. Effect of Hospital Pharmacist Counseling on Clinical Outcomes of Type 2 Diabetes Mellitus Outpatients. J Res Pharm Pract. 2019;8(3):155-161. Published 2019 Oct 16. doi:10.4103/jrpp.JRPP_19_67 
  </ref>
  <a><pmid>PMID31728347   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Nuffer W, Trujillo T, Griend JV. Estimated Potential Financial Impact of Pharmacist-Delivered Disease Management Services Across a Network of Pharmacies in Rural Colorado. J Manag Care Spec Pharm. 2019;25(9):984-988. doi:10.18553/jmcp.2019.25.9.984 
  </ref>
  <a><pmid>PMID31456492   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Nuffer W, Trujillo T, Griend JV. Estimated Potential Financial Impact of Pharmacist-Delivered Disease Management Services Across a Network of Pharmacies in Rural Colorado. J Manag Care Spec Pharm. 2019;25(9):984-988. doi:10.18553/jmcp.2019.25.9.984 
  </ref>
  <a><pmid>PMID31456492   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     O'Reilly EA, Cross LV, Hayes JS, Kubiak NT. Impact of pharmacist intervention on glucagon prescribing patterns in an outpatient internal medicine teaching
clinic. J Am Pharm Assoc (2003). 2019 May 16. pii: S1544-3191(19)30152-9. doi:
10.1016/j.japh.2019.04.009. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID31104980   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Nagy MW, Gruber S, McConnell M. Implementation of a Pilot Pharmacist
Testosterone Therapy Management Service. J Pharm Pract. 2019 Feb
21:897190019830251. doi: 10.1177/0897190019830251. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID30791810   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Anderson C, Zhan K, Boyd M, Mann C. The role of pharmacists in general
practice: A realist review. Res Social Adm Pharm. 2019 Apr;15(4):338-345. doi:
10.1016/j.sapharm.2018.06.001. Epub 2018 Jun 12. Review. 
  </ref>
  <a><pmid>PMID29907317   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bloom CI, Ku M, Williams M. Clinical pharmacy specialists' impact in patient aligned care teams for type 2 diabetes management. J Am Pharm Assoc (2003). 2019;59(5):717‐721. doi:10.1016/j.japh.2019.05.002 
  </ref>
  <a><pmid>PMID31204200   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bloom CI, Ku M, Williams M. Clinical pharmacy specialists' impact in patient aligned care teams for type 2 diabetes management. J Am Pharm Assoc (2003). 2019;59(5):717‐721. doi:10.1016/j.japh.2019.05.002 
  </ref>
  <a><pmid>PMID31204200   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Batta RA, Kasabri V, Akour A, Hyassat D, Albsoul-Younes A. Impact of clinical pharmacists intervention on management of hyperglycemia in&nbsp;pregnancy in Jordan.
Int J Clin Pharm. 2017 Nov 14. doi: 10.1007/s11096-017-0550-3. [Epub ahead of
print] 
  </ref>
  <a><pmid>PMID29134488   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Van Eikenhorst L, Taxis K, van Dijk L, de Gier H. Pharmacist-Led Self-management Interventions to Improve Diabetes Outcomes: A Systematic Literature Review and Meta-Analysis. Front Pharmacol. 2017 Dec 14;8:891. doi: 10.3389/fphar.2017.00891. eCollection 2017. Review. 
  </ref>
  <a><pmid>PMID29311916   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fazel MT, Bagalagel A, Lee JK, Martin JR, Slack MK. Impact of Diabetes Care by
Pharmacists as Part of Health Care Team in Ambulatory Settings: A Systematic
Review and Meta-analysis. Ann Pharmacother. 2017 Oct;51(10):890-907. doi:
10.1177/1060028017711454. Epub 2017 Jun 2. Review. 
  </ref>
  <a><pmid>PMID28573873   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Lee M, Vachon A,
Iliadis TL, Hollands W, Elman S, Kraft JM, Naseem S, Doheny S, Lee J, Barberio J,
Patel L, Khan NF, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD.
Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance
Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes:
The STIC2IT Cluster Randomized Clinical Trial. JAMA Intern Med. 2018 Sep
1;178(9):1182-1189. doi: 10.1001/jamainternmed.2018.3189. 
  </ref>
  <a><pmid>PMID30083727   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Stanton-Robinson C, Al-Jumaili AA, Jackson A, Catney C, Veach S, Witry MJ.
Evaluation of community pharmacist-provided telephone interventions to improve
adherence to hypertension and diabetes medications. J Am Pharm Assoc (2003). 2018
Jul - Aug;58(4S):S120-S124. doi: 10.1016/j.japh.2018.04.030. Epub 2018 Jun 8. 
  </ref>
  <a><pmid>PMID29891173   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rosenberg-Yunger ZRS, Verweel L, Gionfriddo MR, MacCallum L, Dolovich L.
Community pharmacists' perspectives on shared decision-making in diabetes
management. Int J Pharm Pract. 2018 Oct;26(5):414-422. doi: 10.1111/ijpp.12422.
Epub 2017 Dec 26. 
  </ref>
  <a><pmid>PMID29277945   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gobis B, Kapanen AI, Reardon J, Min J, Li KH, Lynd LD, Zed PJ. Cardiovascular Risk Reduction in the Workplace With CAMMPUS (Cardiovascular Assessment and
Medication Management by Pharmacists at the UBC Site). Ann Pharmacother. 2019
Jun;53(6):574-580. doi: 10.1177/1060028018823330. Epub 2019 Jan 13. 
  </ref>
  <a><pmid>PMID30638031   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Moczygemba LR, Bhathena S, DiPiro CV, Snead R. Pharmacist documentation of
gaps in care identified during diabetes coaching. J Am Pharm Assoc (2003). 2019
Jan - Feb;59(1):57-63. doi: 10.1016/j.japh.2018.09.002. Epub 2018 Nov 13. 
  </ref>
  <a><pmid>PMID30446422   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Saavedra-Mitjans M, Ferrand É, Garin N, Bussières JF. Role and impact of
pharmacists in Spain: a scoping review. Int J Clin Pharm. 2018
Dec;40(6):1430-1442. doi: 10.1007/s11096-018-0740-7. Epub 2018 Oct 26. Review. 
  </ref>
  <a><pmid>PMID30367376   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     San-Juan-Rodriguez A, Newman TV, Hernandez I, Swart ECS, Klein-Fedyshin M,
Shrank WH, Parekh N. Impact of community pharmacist-provided preventive services on clinical, utilization, and economic outcomes: An umbrella review. Prev Med.
2018 Oct;115:145-155. doi: 10.1016/j.ypmed.2018.08.029. Epub 2018 Aug 23. 
  </ref>
  <a><pmid>PMID30145351   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Delgado HM, Kleinman NP, Makarem AF, Nguyen C. Implementing California Senate Bill 493 in an Outpatient Pharmacy Within an Integrated Health System: Evaluation of the Operational and Clinical Effect of Pharmacist-Ordered Laboratory Tests. J Manag Care Spec Pharm. 2020;26(3):320‐324. doi:10.18553/jmcp.2020.26.3.320 
  </ref>
  <a><pmid>PMID32105181   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Siaw MYL, Ko Y, Malone DC, Tsou KYK, Lew YJ, Foo D, Tan E, Chan SC, Chia A,
Sinaram SS, Goh KC, Lee JY. Impact of pharmacist-involved collaborative care on
the clinical, humanistic and cost outcomes of high-risk patients with type 2
diabetes (IMPACT): a randomized controlled trial. J Clin Pharm Ther. 2017 Apr 27.
doi: 10.1111/jcpt.12536. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID28449205   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sullivan J, Jett BP, Cradick M, Zuber J. Effect of Clinical Pharmacist
Intervention on Hemoglobin A1C Reduction in Veteran Patients With Type 2 Diabetes
in a Rural Setting. Ann Pharmacother. 2016 Dec;50(12):1023-1027. Epub 2016 Aug 5. 
  </ref>
  <a><pmid>PMID27497068   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ichiki Y, Kobayashi D, Kubota T, Ozono S, Murakami A, Yamakawa Y, Zeki K,
Shimazoe T. Effect of Patient Education for Diabetic Outpatients by a Hospital
Pharmacist: A Retrospective Study. Yakugaku Zasshi. 2016 Dec 1;136(12):1667-1674.
Epub 2016 Aug 29. 
  </ref>
  <a><pmid>PMID27569574   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Martinez J, Laswell E, Cailor S, Ballentine J. Frequency and Impact of
Pharmacist Interventions in Clinical Trial Patients With Diabetes. Clin Ther.
2017 Apr;39(4):714-722. doi: 10.1016/j.clinthera.2017.02.006. Epub 2017 Mar 9. 
  </ref>
  <a><pmid>PMID28285724   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Erku DA, Ayele AA, Mekuria AB, Belachew SA, Hailemeskel B, Tegegn HG. The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study. Pharm Pract (Granada). 2017 Jul-Sep;15(3):1026. doi: 10.18549/PharmPract.2017.03.1026. Epub 2017 Aug 26. 
  </ref>
  <a><pmid>PMID28943985   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Yaghoubi M, Mansell K, Vatanparastc H, Steeves M, Zeng W, Farag M. Effects of Pharmacy-Based Interventions on the Control and Management of Diabetes in Adults:
A Systematic Review and Meta-Analysis. Can J Diabetes. 2017 Dec;41(6):628-641.
doi: 10.1016/j.jcjd.2017.09.014. Review. 
  </ref>
  <a><pmid>PMID29224636   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chavez B, Kosirog E, Brunner JM. Impact of a Bilingual Pharmacy Diabetes
Service in a Federally Qualified Health Center. Ann Pharmacother. 2018
Dec;52(12):1218-1223. doi: 10.1177/1060028018781852. Epub 2018 Jun 5. 
  </ref>
  <a><pmid>PMID29871511   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Peterson J, Hinds A, Garza A, Barner J, Hill L, Nguyen M, Lai P, Gums T.
Impact of Physician-Pharmacist Covisits at a Primary Care Clinic in Patients With
Uncontrolled Diabetes. J Pharm Pract. 2018 Nov 14:897190018807374. doi:
10.1177/0897190018807374. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID30428760   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Michiels Y, Bugnon O, Chicoye A, Dejager S, Moisan C, Allaert FA, Hunault C,
Romengas L, Méchin H, Vergès B. Impact of a Community Pharmacist-Delivered
Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster
Randomized Controlled Study. Adv Ther. 2019 Jun;36(6):1291-1303. doi:
10.1007/s12325-019-00957-y. Epub 2019 May 2. 
  </ref>
  <a><pmid>PMID31049873   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hammad EA, Qudah RA, Akour AA. The impact of clinical pharmacists in improving
Jordanian patients' health outcomes. Saudi Med J. 2017 Nov;38(11):1077-1089. doi:
10.15537/smj.2017.11.21453. Review. 
  </ref>
  <a><pmid>PMID29114694   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pousinho S, Morgado M, Falcão A, Alves G. Pharmacist Interventions in the
Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized
Controlled Trials. J Manag Care Spec Pharm. 2016 May;22(5):493-515. doi:
10.18553/jmcp.2016.22.5.493. 
  </ref>
  <a><pmid>PMID27123912   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Khan Mohammed A, Medarametla C, Rabbani MM, Prashanthi K. Role of a clinical
pharmacist in managing diabetic nephropathy: an approach of pharmaceutical care
plan. J Diabetes Metab Disord. 2015 Oct 26;14:82. doi: 10.1186/s40200-015-0213-7.
eCollection 2015. 
  </ref>
  <a><pmid>PMID26504769   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Al Hamarneh YN, Sauriol L, Tsuyuki RT. After the diabetes care trial ends, now
what? A 1-year follow-up of the RxING study. BMJ Open. 2015 Aug 12;5(8):e008152. doi: 10.1136/bmjopen-2015-008152. 
  </ref>
  <a><pmid>PMID26270946   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Aguiar PM, Brito Gde C, Lima Tde M, Santos AP, Lyra DP Jr, Storpirtis S.
Investigating Sources of Heterogeneity in Randomized Controlled Trials of the
Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic
Patients: A Systematic Review and Meta-Analysis. PLoS One. 2016 Mar
10;11(3):e0150999. doi: 10.1371/journal.pone.0150999. eCollection 2016. Review. 
  </ref>
  <a><pmid>PMID26963251   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Soto A, Avila X, Cordova P, Fernandez P, Lopez M, Villa LA, Morales F. Impact of a pharmacotherapy plan to improve adherence for patients with type-2 diabetes and hypertension in a Chilean hospital. Int J Clin Pharm. 2015 Oct;37(5):734-8.
doi: 10.1007/s11096-015-0131-2. Epub 2015 May 26. 
  </ref>
  <a><pmid>PMID26008218   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mohammed MA, Moles RJ, Chen TF. Impact of Pharmaceutical Care Interventions on
Health-Related Quality-of-Life Outcomes: A Systematic Review and Meta-analysis.
Ann Pharmacother. 2016 Oct;50(10):862-81. doi: 10.1177/1060028016656016. Review. 
  </ref>
  <a><pmid>PMID27363846   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Breuker C, Abraham O, di Trapanie L, Mura T, Macioce V, Boegner C, Jalabert A,
Villiet M, Castet-Nicolas A, Avignon A, Sultan A. Patients with diabetes are at
high risk of serious medication errors at hospital: Interest of clinical
pharmacist intervention to improve healthcare. Eur J Intern Med. 2017
Mar;38:38-45. doi: 10.1016/j.ejim.2016.12.003. 
  </ref>
  <a><pmid>PMID28007439   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Langran T, Nanda N, Bataveljic A, Gonzalez-Durio J. Supporting the management of type 2 diabetes with pharmacist-led reviews: an observational analysis. BMJ Open. 2017 Mar 3;7(3):e013451. doi: 10.1136/bmjopen-2016-013451. 
  </ref>
  <a><pmid>PMID28259852   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Al Hamarneh YN, Hemmelgarn BR, Hassan I, Jones CA, Tsuyuki RT. The
Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult
Patients with Type 2 Diabetes: The Multicentre Randomized Controlled R(x)EACH
Trial. Can J Diabetes. 2017 Dec;41(6):580-586. doi: 10.1016/j.jcjd.2017.08.244.
Epub 2017 Sep 28. 
  </ref>
  <a><pmid>PMID28965748   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Al Hamarneh YN, Tsuyuki RT, Jones CA, Manns B, Tonelli M, Scott-Douglass N,
Jindal K, Tink W, Hemmelgarn BR. Effectiveness of Pharmacist Interventions on
Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized
Controlled R(x)EACH Trial. Am J Kidney Dis. 2018 Jan;71(1):42-51. doi:
10.1053/j.ajkd.2017.07.012. Epub 2017 Sep 12. 
  </ref>
  <a><pmid>PMID28912054   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Korcegez EI, Sancar M, Demirkan K. Effect of a Pharmacist-Led Program on
Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern
Cyprus: A Randomized Controlled Trial. J Manag Care Spec Pharm. 2017
May;23(5):573-582. doi: 10.18553/jmcp.2017.23.5.573. 
  </ref>
  <a><pmid>PMID28448779   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Aneese NJ, Halalau A, Muench S, Shelden D, Fett J, Lauster C. Impact of a
pharmacist-managed diabetes clinic on quality measures. Am J Manag Care. 2018
Mar;24(4 Spec No.):SP116-SP119. 
  </ref>
  <a><pmid>PMID29689147   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Prudencio J, Cutler T, Roberts S, Marin S, Wilson M. The Effect of Clinical
Pharmacist-Led Comprehensive Medication Management on Chronic Disease State Goal Attainment in a Patient-Centered Medical Home. J Manag Care Spec Pharm. 2018
May;24(5):423-429. doi: 10.18553/jmcp.2018.24.5.423. 
  </ref>
  <a><pmid>PMID29694290   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Deters MA, Laven A, Castejon A, Doucette WR, Ev LS, Krass I, Mehuys E,
Obarcanin E, Schwender H, Laeer S. Effective Interventions for Diabetes Patients by Community Pharmacists: A Meta-analysis of Pharmaceutical Care Components. Ann Pharmacother. 2018 Feb;52(2):198-211. doi: 10.1177/1060028017733272. Epub 2017
Sep 26. 
  </ref>
  <a><pmid>PMID28948839   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Newland DM, Edwards AR, Hall RC, Maxwell PR. Positive Impact of a Pilot
Pharmacist-Run Diabetes Pharmacotherapy Clinic in Solid-Organ Transplant
Recipients. Diabetes Spectr. 2018 May;31(2):167-176. doi: 10.2337/ds17-0029. 
  </ref>
  <a><pmid>PMID29773937   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Cowart K, Sando K. Pharmacist Impact on Treatment Intensification and
Hemoglobin A(1C) in Patients With Type 2 Diabetes Mellitus at an Academic Health Center. J Pharm Pract. 2018 Jan 1:897190018776178. doi: 10.1177/0897190018776178.
[Epub ahead of print] 
  </ref>
  <a><pmid>PMID29768945   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sarayani A, Mashayekhi M, Nosrati M, Jahangard-Rafsanjani Z, Javadi M, Saadat N, Najafi S, Gholami K. Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice. Int J Clin Pharm. 2018 Apr;40(2):345-353. doi: 10.1007/s11096-018-0593-0. Epub 2018 Feb 12. 
  </ref>
  <a><pmid>PMID29435911   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Goedken AM, Butler CM, McDonough RP, Deninger MJ, Doucette WR. Continuous
Medication Monitoring (CoMM): A foundational model to support the clinical work
of community pharmacists. Res Social Adm Pharm. 2018 Jan;14(1):106-111. doi:
10.1016/j.sapharm.2016.12.008. Epub 2017 Jan 2. 
  </ref>
  <a><pmid>PMID28087207   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bharadia R, Lorenz K, Cor K, Simpson SH. Financial remuneration is positively correlated with the number of clinical activities: an example from diabetes
management in Alberta community pharmacies. Int J Pharm Pract. 2018
Feb;26(1):77-80. doi: 10.1111/ijpp.12331. Epub 2017 Feb 27. 
  </ref>
  <a><pmid>PMID28240395   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Matzke GR, Moczygemba LR, Williams KJ, Czar MJ, Lee WT. Impact of a
pharmacist-physician collaborative care model on patient outcomes and health
services utilization. Am J Health Syst Pharm. 2018 Jul 15;75(14):1039-1047. doi: 10.2146/ajhp170789. Epub 2018 May 22. 
  </ref>
  <a><pmid>PMID29789318   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lee EL, Wong PS, Tan MY, Sheridan J. What role could community pharmacists in Malaysia play in diabetes self-management education and support? The views of
individuals with type 2 diabetes. Int J Pharm Pract. 2018 Apr;26(2):138-147. doi:
10.1111/ijpp.12374. Epub 2017 Jun 2. 
  </ref>
  <a><pmid>PMID28574154   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Morath B, Mayer T, Send AFJ, Hoppe-Tichy T, Haefeli WE, Seidling HM. Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions: a review with a systematic approach. Br J Clin Pharmacol. 2017 Oct;83(10):2163-2178. doi: 10.1111/bcp.13318. Epub 2017 Jun 14. Review. 
  </ref>
  <a><pmid>PMID28452063   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Milosavljevic A, Aspden T, Harrison J. Community pharmacist-led interventions and their impact on patients' medication adherence and other health outcomes: a
systematic review. Int J Pharm Pract. 2018 Oct;26(5):387-397. doi:
10.1111/ijpp.12462. Epub 2018 Jun 21. 
  </ref>
  <a><pmid>PMID29927005   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Aguiar PM, da Silva CH, Chiann C, Dórea EL, Lyra DP Jr, Storpirtis S.
Pharmacist-physician collaborative care model for patients with uncontrolled type
2 diabetes in Brazil: results from a randomized controlled trial. J Eval Clin
Pract. 2016 Jul 25. doi: 10.1111/jep.12606. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID27452158   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Al Hamarneh YN, Charrois T, Lewanczuk R, Tsuyuki RT. Pharmacist intervention
for glycaemic control in the community (the RxING study). BMJ Open. 2013 Sep
24;3(9):e003154. doi: 10.1136/bmjopen-2013-003154. Erratum in: BMJ Open.
2013;3(10):e003154corr1. 
  </ref>
  <a><pmid>PMID24068762   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hassali MA, Nazir SU, Saleem F, Masood I. Literature review: pharmacists' interventions to improve control and management in type 2 diabetes mellitus. Altern Ther Health Med. 2015 Jan-Feb;21(1):28-35. Review. PubMed PMID: 25599430. 
  </ref>
  <a><pmid>PMID25599430   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Conley MP, Chim C, Magee CE, Sullivan DJ. A review of advances in collaborative pharmacy practice to improve adherence to standards of care in diabetes management. Curr Diab Rep. 2014 Mar;14(3):470. doi: 10.1007/s11892-013-0470-0. Review. PubMed PMID: 24496918. 
  </ref>
  <a><pmid>PMID24496918   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Selcuk A, Sancar M, Okuyan B, Demirtunc R, Izzettin FV. The potential role of clinical pharmacists in elderly patients during hospital admission. Pharmazie.2015 Aug;70(8):559-62. PubMed PMID: 26380527. 
  </ref>
  <a><pmid>PMID26380527   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wang Y, Yeo QQ, Ko Y. Economic evaluations of pharmacist-managed services in people with diabetes mellitus: a systematic review. Diabet Med. 2015 Oct 3. 
  </ref>
  <a><pmid>PMID26433008   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Simpson SH, Lier DA, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson
JA. Cost-effectiveness analysis of adding pharmacists to primary care teams to
reduce cardiovascular risk in patients with Type&nbsp;2 diabetes: results from a
randomized controlled trial. Diabet Med. 2015 Jul;32(7):899-906. doi:
10.1111/dme.12692. Epub 2015 Feb 2. 
  </ref>
  <a><pmid>PMID25594919   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Brown S, Al Hamarneh YN, Tsuyuki RT, Nehme K, Sauriol L. Economic analysis of insulin initiation by pharmacists in a Canadian setting: The RxING study. Can Pharm J (Ott). 2016 May;149(3):130-7. doi: 10.1177/1715163516640813. Epub 2016
Apr 5. 
  </ref>
  <a><pmid>PMID27212963   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Cani CG, Lopes Lda S, Queiroz M, Nery M. Improvement in medication adherence
and self-management of diabetes with a clinical pharmacy program: a randomized
controlled trial in patients with type 2 diabetes undergoing insulin therapy at a
teaching hospital. Clinics (Sao Paulo). 2015 Feb;70(2):102-6. doi:
10.6061/clinics/2015(02)06. 
  </ref>
  <a><pmid>PMID25789518   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Omboni S, Sala E. The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring. Expert Rev Cardiovasc
Ther. 2015 Feb;13(2):209-21. doi: 10.1586/14779072.2015.1001368. Epub 2015 Jan
12. Review. 
  </ref>
  <a><pmid>PMID25578090   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Carter BL, Levy BT, Gryzlak B, Chrischilles EA, Vander Weg MW, Christensen AJ,
James PA, Moss CA, Parker CP, Gums T, Finkelstein RJ, Xu Y, Dawson JD, Polgreen
LA. A centralized cardiovascular risk service to improve guideline adherence in
private primary care offices. Contemp Clin Trials. 2015 Jul;43:25-32. doi:
10.1016/j.cct.2015.04.014. Epub 2015 May 4. 
  </ref>
  <a><pmid>PMID25952471   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Dischinger HR, Cheng E, Mann AD, Grueber TM, Hawk S, Davis LA, Prochazka AV,
Hutt E, Caplan L. Decisional support to prevent adverse drug reactions of long
latency: pilot randomized controlled intervention for glucocorticoid-induced
diabetes. J Eval Clin Pract. 2015 Aug;21(4):614-9. doi: 10.1111/jep.12351. Epub
2015 Apr 7. 
  </ref>
  <a><pmid>PMID25851076   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Niedrig D, Krattinger R, Jödicke A, Gött C, Bucklar G, Russmann S.
Development, implementation and outcome analysis of semi-automated alerts for
metformin dose adjustment in hospitalized patients with renal impairment.
Pharmacoepidemiol Drug Saf. 2016 Oct;25(10):1204-1209. doi: 10.1002/pds.4062. 
  </ref>
  <a><pmid>PMID27418265   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chung AY, Anand S, Wong IC, Tan KC, Wong CF, Chui WC, Chan EW. Improving
medication safety and diabetes management in Hong Kong: a multidisciplinary
approach. Hong Kong Med J. 2017 Apr;23(2):158-67. doi: 10.12809/hkmj165014. Epub 2017 Mar 17. 
  </ref>
  <a><pmid>PMID28302923   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Huber CA, Reich O. Medication adherence in patients with diabetes mellitus:
does physician drug dispensing enhance quality of care? Evidence from a large
health claims database in Switzerland. Patient Prefer Adherence. 2016 Sep
15;10:1803-1809. eCollection 2016. 
  </ref>
  <a><pmid>PMID27695299   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pugazhenthi V, Dick TB, Call M. Outcomes of a pharmacist-managed glucose
collaborative practice agreement. Am J Health Syst Pharm. 2016 Dec 1;73(23
Supplement 6):S148-S154. 
  </ref>
  <a><pmid>PMID27864238   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Meade LT, Tart RC, Buzby HL. Evaluation of Diabetes Education and Pharmacist
Interventions in a Rural, Primary Care Setting. Diabetes Spectr. 2018
Feb;31(1):90-95. doi: 10.2337/ds16-0064. 
  </ref>
  <a><pmid>PMID29456431   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Moreau C, Sando KR, Zambrano DH. Assessing the Effect of Pharmacist Care on
Diabetes-Related Outcomes in a Rural Outpatient Clinic: A Retrospective
Case-Control Study. Ann Pharmacother. 2017 Jun;51(6):473-478. doi:
10.1177/1060028016685731. Epub 2017 Jan 7. 
  </ref>
  <a><pmid>PMID28064508   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ourth H, Nelson J, Spoutz P, Morreale AP. Development of a Pharmacoeconomic
Model to Demonstrate the Effect of Clinical Pharmacist Involvement in Diabetes
Management. J Manag Care Spec Pharm. 2018 May;24(5):449-457. doi:
10.18553/jmcp.2018.24.5.449. 
  </ref>
  <a><pmid>PMID29694293   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Twigg G, Motsko J, Thomas J, David T. Pharmacist-Managed Diabetes Center
Interventions Ensure Quality and Safety in Elderly Patients. Consult Pharm. 2017 May 1;32(5):299-310. doi: 10.4140/TCP.n.2017.299. 
  </ref>
  <a><pmid>PMID28483010   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Maeng DD, Graham J, Bogart M, Hao J, Wright EA. Impact of a pharmacist-led
diabetes management on outcomes, utilization, and cost. Clinicoecon Outcomes Res.
2018 Sep 24;10:551-562. doi: 10.2147/CEOR.S174595. eCollection 2018. 
  </ref>
  <a><pmid>PMID30288070   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gatwood JD, Chisholm-Burns M, Davis R, Thomas F, Potukuchi P, Hung A, Shawn McFarland M, Kovesdy CP. Impact of pharmacy services on initial clinical outcomes and medication adherence among veterans with uncontrolled diabetes. BMC Health Serv Res. 2018 Nov 14;18(1):855. doi: 10.1186/s12913-018-3665-x. 
  </ref>
  <a><pmid>PMID30428877   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Savanovitch C, Bedhomme S, Van Lander A, Prunet-Spano C, Vennat B. [IPADAM quali study: Intervention of the Pharmacist in the Issue of Self-medication: Experience of pharmacy team focus groups and patients' perceptions]. Ann Pharm Fr. 2018 Sep;76(5):399-407. doi: 10.1016/j.pharma.2018.04.001. Epub 2018 May 22. French. 
  </ref>
  <a><pmid>PMID29801716   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hall NJ, Donovan G, Wilkes S. A qualitative synthesis of pharmacist, other
health professional and lay perspectives on the role of community pharmacy in
facilitating care for people with long-term conditions. Res Social Adm Pharm.
2018 Nov;14(11):1043-1057. doi: 10.1016/j.sapharm.2018.01.002. Epub 2018 Jan 4. 
  </ref>
  <a><pmid>PMID29331530   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Antoine SL, Pieper D, Mathes T, Eikermann M. Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials. BMC Endocr Disord. 2014 Jul 7;14:53. doi: 10.1186/1472-6823-14-53. Review. PubMed PMID: 25001374; PubMed Central PMCID: PMC4105396. 
  </ref>
  <a><pmid>PMID25001374   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bluml BM, Watson LL, Skelton JB, Manolakis PG, Brock KA. Improving outcomes for diverse populations disproportionately affected by diabetes: final results of Project IMPACT: Diabetes. J Am Pharm Assoc (2003). 2014 Sep-Oct;54(5):477-85. doi: 10.1331/JAPhA.2014.13240. PubMed PMID: 25216877. 
  </ref>
  <a><pmid>PMID25216877   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Meece J. Improving medication adherence among patients with type 2 diabetes. J Pharm Pract. 2014 Apr;27(2):187-94. doi: 10.1177/0897190013513803. Epub 2013 Dec 27. Review. PubMed PMID: 24375997. 
  </ref>
  <a><pmid>PMID24375997   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Johnson C, Ruisinger JF, Bates J, Barnes BJ. Impact of a community-based diabetes self-management program on key metabolic parameters. Pharm Pract (Granada). 2014 Oct;12(4):499. Epub 2014 Mar 15. PubMed PMID: 25580174; PubMed Central PMCID: PMC4282769. 
  </ref>
  <a><pmid>PMID25580174   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Santschi V, Chiolero A, Colosimo AL, Platt RW, Taffé P, Burnier M, Burnand B, Paradis G. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014 Apr 10;3(2):e000718. doi: 10.1161/JAHA.113.000718. Review. PubMed PMID: 24721801; PubMed Central PMCID: PMC4187511 
  </ref>
  <a><pmid>PMID24721801   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Obarcanin E, Krüger M, Müller P, Nemitz V, Schwender H, Hasanbegovic S, Kalajdzisalihovic S, Läer S. Pharmaceutical care of adolescents with diabetes mellitus type 1: the DIADEMA study, a randomized controlled trial. Int J Clin Pharm. 2015 Apr 28. [Epub ahead of print] PubMed PMID: 25917376 
  </ref>
  <a><pmid>PMID25917376   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Elliott RA, Boyd MJ, Salema NE, Davies J, Barber N, Mehta RL, Tanajewski L,
Waring J, Latif A, Gkountouras G, Avery AJ, Chuter A, Craig C. Supporting
adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine
Service. BMJ Qual Saf. 2015 Dec 8. pii: bmjqs-2015-004400. doi:
10.1136/bmjqs-2015-004400. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID26647412   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lee VW, Choi LM, Wong WJ, Chung HW, Ng CK, Cheng FW. Pharmacist intervention in the prevention of heart failure for high-risk elderly patients in the community. BMC Cardiovasc Disord. 2015 Dec 24;15(1):178. 
  </ref>
  <a><pmid>PMID26702612   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Dempsey JT, Matta LS, Carter DM, Stevens CA, Stevenson LW, Desai AS, Cheng JW.
Assessment of Drug Therapy-Related Issues in an Outpatient Heart Failure
Population and the Potential Impact of Pharmacist-Driven Intervention. J Pharm
Pract. 2016 Apr 13. pii: 0897190016641491. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID27080398   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Shaya FT, Chirikov VV, Rochester C, Zaghab RW, Kucharski KC. Impact of a
comprehensive pharmacist medication-therapy management service. J Med Econ.
2015;18(10):828-37. doi: 10.3111/13696998.2015.1052463. Epub 2015 Jun 9. 
  </ref>
  <a><pmid>PMID25985395   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Shane-McWhorter L, McAdam-Marx C, Lenert L, Petersen M, Woolsey S, Coursey JM,
Whittaker TC, Hyer C, LaMarche D, Carroll P, Chuy L. Pharmacist-provided diabetes
management and education via a telemonitoring program. J Am Pharm Assoc (2003).
2015 Sep-Oct;55(5):516-26. doi: 10.1331/JAPhA.2015.14285. 
  </ref>
  <a><pmid>PMID26359961   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Skinner JS, Poe B, Hopper R, Boyer A, Wilkins CH. Assessing the effectiveness of pharmacist-directed medication therapy management in improving diabetes
outcomes in patients with poorly controlled diabetes. Diabetes Educ. 2015
Aug;41(4):459-65. doi: 10.1177/0145721715587563. Epub 2015 May 25. 
  </ref>
  <a><pmid>PMID26009557   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rashid JR, Leath BA, Truman BI, Atkinson DD, Gary LC, Manian N. Translating
Comparative Effectiveness Research Into Practice: Effects of Interventions on
Lifestyle, Medication Adherence, and Self-care for Type 2 Diabetes, Hypertension,
and Obesity Among Black, Hispanic, and Asian Residents of Chicago and Houston,
2010 to 2013. J Public Health Manag Pract. 2017 Mar 1. doi:
10.1097/PHH.0000000000000525. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID28257397   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Quinones ME, Pio MY, Chow DH, Moss E, Hulstein JL, Boatright SM, Mathew A.
Impact of clinical pharmacy services on outcomes and costs for indigent patients with diabetes. Am J Manag Care. 2016 Apr 1;22(4):e147-52. 
  </ref>
  <a><pmid>PMID27143351   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Benedict AW, Spence MM, Sie JL, Chin HA, Ngo CD, Salmingo JF, Vidaurreta AT,
Rashid N. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care
Setting Within an Integrated Health Care System. J Manag Care Spec Pharm. 2018
Feb;24(2):114-122. doi: 10.18553/jmcp.2018.24.2.114. 
  </ref>
  <a><pmid>PMID29384029   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     El Hajj MS, Abu Yousef SE, Basri MA. Diabetes care in Qatar: a survey of
pharmacists' activities, attitudes and knowledge. Int J Clin Pharm. 2018
Feb;40(1):84-93. doi: 10.1007/s11096-017-0562-z. Epub 2017 Nov 17. 
  </ref>
  <a><pmid>PMID29147964   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Murphy JA, Schroeder MN, Ridner AT, Gregory ME, Whitner JB, Hackett SG. Impact
of a Pharmacy-Initiated Inpatient Diabetes Patient Education Program on 30-Day
Readmission Rates. J Pharm Pract. 2019 Feb 27:897190019833217. doi:
10.1177/0897190019833217. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID30813832   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kraemer DF, Kradjan WA, Bianco TM, Low JA. A randomized study to assess the impact of pharmacist counseling of employer-based health plan beneficiaries with diabetes: the EMPOWER study. J Pharm Pract. 2012 Apr;25(2):169-79. Epub 2011 Oct 10 
  </ref>
  <a><pmid>PMID21987530   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Heisler M, Hofer TP, Schmittdiel JA, Selby JV, Klamerus ML, Bosworth HB, Bermann M, Kerr EA. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation 
  </ref>
  <a><pmid>PMID22570370   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wertz D, Hou L, DeVries A, Dupclay L Jr, McGowan F, Malinowski B, Cziraky MJ. Clinical and economic outcomes of the Cincinnati Pharmacy Coaching Program for diabetes and hypertension. Manag Care. 2012 Mar;21(3):44-54. 
  </ref>
  <a><pmid>PMID22471165   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pinto SL, Bechtol RA, Partha G. Evaluation of outcomes of a medication therapy management program for patients with diabetes. J Am Pharm Assoc (2003). 2012 Jul-Aug;52(4):519-23. 
  </ref>
  <a><pmid>PMID22825233   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Aguiar PM, Brito GD, Correr CJ, Lyra Júnior DP, Storpirtis S. Exploring the Quality of Systematic Reviews on Pharmacist Interventions in Patients With Diabetes: An Overview. Ann Pharmacother. 2014 Apr 1;48(7):887-896. [Epub ahead of print] Review. PubMed PMID: 24692605. 
  </ref>
  <a><pmid>PMID24692605   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Penm J, Li Y, Zhai S, Hu Y, Chaar B, Moles R. The impact of clinical pharmacy services in China on the quality use of medicines: a systematic review in context of China's current healthcare reform. Health Policy Plan. 2014 Oct;29(7):849-872.Epub 2013 Sep 19. Review. PubMed PMID: 24056897 
  </ref>
  <a><pmid>PMID24056897   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Santschi V, Chiolero A, Paradis G, Colosimo AL, Burnand B. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2012 Dec;35(12):2706-17. doi: 10.2337/dc12-0369. Review. PubMed PMID: 23173140; PubMed Central PMCID: PMC3507563. 
  </ref>
  <a><pmid>PMID23173140   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hetro A, Rossetto J, Bahlawan N, Ryan M. Clinical pharmacists supporting patients with diabetes and/or hyperlipidemia in a military medical home. J Am Pharm Assoc (2003). 2015 Jan-Feb;55(1):73-6. doi: 10.1331/JAPhA.2015.14103. PubMed PMID: 25539358 
  </ref>
  <a><pmid>PMID25539358   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Arcebido R, Wong E, Cohen V, Likourezos A. Pharmacist-led discharge counseling on subcutaneous insulin use and administration. Am J Health Syst Pharm. 2013 Aug 15;70(16):1371-3. doi: 10.2146/ajhp120571. PubMed PMID: 23903474. 
  </ref>
  <a><pmid>PMID23903474   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Collier IA, Baker DM. Implementation of a pharmacist-supervised outpatient diabetes treatment clinic. Am J Health Syst Pharm. 2014 Jan 1;71(1):27-36. doi: 10.2146/ajhp130200. PubMed PMID: 24352179. 
  </ref>
  <a><pmid>PMID24352179   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Schumacher C, Glosner SE. Assessment of pain and impact of care among patients with painful diabetic peripheral neuropathy. J Am Pharm Assoc (2003). 2014 Jan-Feb;54(1):14-8. doi: 10.1331/JAPhA.2014.13049. PubMed PMID: 24257634. 
  </ref>
  <a><pmid>PMID24257634   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Shawn McFarland M, Wallace JP, Parra J, Baker J. Evaluation of patient satisfaction with diabetes management provided by clinical pharmacists in the patient-centered medical home. Patient. 2014;7(1):115-21. doi: 10.1007/s40271-013-0039-7. PubMed PMID: 24353054. 
  </ref>
  <a><pmid>PMID24353054   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Farsaei S, Karimzadeh I, Elyasi S, Hatamkhani S, Khalili H. Glycemic control in the infectious diseases ward; role of clinical pharmacist interventions. J Infect Dev Ctries. 2014 Apr 15;8(4):480-9. doi: 10.3855/jidc.3357. PubMed PMID: 24727515. 
  </ref>
  <a><pmid>PMID24727515   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Watson LL, Bluml BM. Integrating pharmacists into diverse diabetes care teams: implementation tactics from Project IMPACT: Diabetes. J Am Pharm Assoc (2003). 2014 Sep-Oct;54(5):538-41. doi: 10.1331/JAPhA.2014.14063. PubMed PMID: 25216884. 
  </ref>
  <a><pmid>PMID25216884   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     McAdam-Marx C, Dahal A, Jennings B, Singhal M, Gunning K. The effect of a
diabetes collaborative care management program on clinical and economic outcomes in patients with type 2 diabetes. J Manag Care Spec Pharm. 2015 Jun;21(6):452-68. 
  </ref>
  <a><pmid>PMID26011547   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ko JJ, Lu J, Rascati K, Stock EM, Juan J, Suh K, Kim Y, Tabor PA, Godley PJ.
Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in
Patients with Type 2 Diabetes. J Manag Care Spec Pharm. 2016 Jan;22(1):32-7. doi:
10.18553/jmcp.2016.22.1.32. 
  </ref>
  <a><pmid>PMID27015049   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lamb KD, Baker JW, McFarland MS. Implementation of a pharmacotherapy clinic
into the patient centered medical home model by a second year pharmacy resident. Am J Health Syst Pharm. 2015 Sep 1;72(17 Suppl 2):S83-9. doi: 10.2146/sp150015. 
  </ref>
  <a><pmid>PMID26272898   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kharjul M, Braund R, Green J. The influence of pharmacist-led adherence
support on glycaemic control in people with type 2 diabetes. Int J Clin Pharm.
2018 Apr;40(2):354-359. doi: 10.1007/s11096-018-0606-z. Epub 2018 Feb 21. 
  </ref>
  <a><pmid>PMID29468528   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Singh RF, Kelly P, Tam A, Bronner J, Morello CM, Hirsch JD. Evaluation of a
short, interactive diabetes self-management program by pharmacists for type 2
diabetes. BMC Res Notes. 2018 Nov 26;11(1):828. doi: 10.1186/s13104-018-3952-y. 
  </ref>
  <a><pmid>PMID30477584   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Schenk RJ Jr, Schenk J. Integration of remote blood glucose meter upload technology into a clinical pharmacist medication therapy management service. J Diabetes Sci Technol. 2011 Jan 1;5(1):188-91 
  </ref>
  <a><pmid>PMID21303643   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ko GT, Yeung CY, Leung WY, Chan KW, Chung CH, Fung LM, Ip TP, Kum G, Lau KP, Lau IT, Li JK, Siu SC, Tsang MW, Yeung VT, Tong PC, So WY, Chan JC. Cost implication of team-based structured versus usual care for type 2 diabetic patients with chronic renal disease. Hong Kong Med J. 2011 Dec;17 Suppl 6:9-12 
  </ref>
  <a><pmid>PMID22147352   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Simpson SH, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson JA. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2011 Jan;34(1):20-6. Epub 2010 Oct 7 
  </ref>
  <a><pmid>PMID20929988   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Padiyara RS, D'Souza JJ, Rihani RS. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group. J Manag Care Pharm. 2011 Jul-Aug;17(6):456-62 
  </ref>
  <a><pmid>PMID21787031   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pape GA, Hunt JS, Butler KL, Siemienczuk J, LeBlanc BH, Gillanders W, Rozenfeld Y, Bonin K. Team-based care approach to cholesterol management in diabetes mellitus: two-year cluster randomized controlled trial. Arch Intern Med. 2011 Sep 12;171(16):1480-6 
  </ref>
  <a><pmid>PMID21911633   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, Giri M. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial. J Clin Pharm Ther. 2011 Oct;36(5):602-13. doi: 10.1111/j.1365 2710.2010.01218.x. Epub 2010 Dec 8 
  </ref>
  <a><pmid>PMID21143256   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mitchell B, Armour C, Lee M, Song YJ, Stewart K, Peterson G, Hughes J, Smith L, Krass I. Diabetes Medication Assistance Service: the pharmacist's role in supporting patient self management of type 2 diabetes (T2DM) in Australia. Patient Educ Couns. 2011 Jun;83(3):288-94. Epub 2011 May 26 
  </ref>
  <a><pmid>PMID21616627   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Collins C, Limone BL, Scholle JM, Coleman CI. Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Res Clin Pract. 2011 May;92(2):145-52. Epub 2010 Oct 20. Review 
  </ref>
  <a><pmid>PMID20961643   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Correr CJ, Melchiors AC, Fernandez-Llimos F, Pontarolo R. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. Int J Clin Pharm. 2011 Apr;33(2):273-80. Epub 2011 Mar 12 
  </ref>
  <a><pmid>PMID21394570   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Cripps RJ, Gourley ES, Johnson W, Cassidy R, Morgan TC, Venugopal D, McFarland MS. An evaluation of diabetes-related measures of control after 6 months of clinical pharmacy specialist intervention. J Pharm Pract. 2011 Jun;24(3):332-8. Epub 2011 Mar 18 
  </ref>
  <a><pmid>PMID21676857   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wallgren S, Berry-Cabán CS, Bowers L. Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility. Ann Pharmacother. 2012 Mar;46(3):353-7. 
  </ref>
  <a><pmid>PMID22395249   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     American Pharmacists Association. DOTx MED: Pharmacist-delivered interventions to improve care for patients with diabetes. J Am Pharm Assoc (2003). 2012 Jan-Feb;52(1):25-33. 
  </ref>
  <a><pmid>PMID22173068   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm. 2012 Sep;18(7):516-26. 
  </ref>
  <a><pmid>PMID22971205   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Blalock SJ, Roberts AW, Lauffenburger JC, Thompson T, O'Connor SK. The effect  of community pharmacy-based interventions on patient health outcomes: a systematic review. Med Care Res Rev. 2013 Jun;70(3):235-66. doi: 10.1177/1077558712459215. Epub 2012 Oct 2. Review. 
  </ref>
  <a><pmid>PMID23035056   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Congdon HB, Dowling TC, Cheng I, Truong HA. Impact of medication therapy management on underserved, primarily Hispanic patients with diabetes. Ann Pharmacother. 2013 May;47(5):665-70. doi: 10.1345/aph.1R648. Epub 2013 Apr 12. PubMed PMID: 23585643. 
  </ref>
  <a><pmid>PMID23585643   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Dhippayom T, Fuangchan A, Tunpichart S, Chaiyakunapruk N. Opportunistic screening and health promotion for type 2 diabetes: an expanding public health role for the community pharmacist. J Public Health (Oxf). 2013 Jun;35(2):262-9. doi: 10.1093/pubmed/fds078. Epub 2012 Sep 12. PubMed PMID: 22976588. 
  </ref>
  <a><pmid>PMID22976588   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Farland MZ, Byrd DC, McFarland MS, Thomas J, Franks AS, George CM, Gross BN, Guirguis AB, Suda KJ. Pharmacist-physician collaboration for diabetes care: the diabetes initiative program. Ann Pharmacother. 2013 Jun;47(6):781-9. doi: 10.1345/aph.1S079. Epub 2013 May 8. PubMed PMID: 23656751. 
  </ref>
  <a><pmid>PMID23656751   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Franklin BE, Farland MZ, Thomas J, McFarland MS, Ray SM, Byrd DC. Pharmacoeconomic analysis of the diabetes initiative program: a pharmacist-physician collaborative care model. Ann Pharmacother. 2013 Dec;47(12):1627-34. doi: 10.1177/1060028013506883. Epub 2013 Oct 16. PubMed PMID: 24259610. 
  </ref>
  <a><pmid>PMID24259610   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Howard-Thompson A, Farland MZ, Byrd DC, Airee A, Thomas J, Campbell J, Cassidy R, Morgan T, Suda KJ. Pharmacist-physician collaboration for diabetes care: cardiovascular outcomes. Ann Pharmacother. 2013 Nov;47(11):1471-7. doi: 10.1177/1060028013504738. PubMed PMID: 24285763. 
  </ref>
  <a><pmid>PMID24285763   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Shah M, Norwood CA, Farias S, Ibrahim S, Chong PH, Fogelfeld L. Diabetes transitional care from inpatient to outpatient setting: pharmacist discharge counseling. J Pharm Pract. 2013 Apr;26(2):120-4. doi: 10.1177/0897190012451907. Epub 2012 Jul 13. PubMed PMID: 22797831. 
  </ref>
  <a><pmid>PMID22797831   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Stange D, Kriston L, von-Wolff A, Baehr M, Dartsch DC. Reducing cardiovascular medication complexity in a German university hospital: effects of a structured pharmaceutical management intervention on adherence. J Manag Care Pharm. 2013 Jun;19(5):396-407. PubMed PMID: 23697477. 
  </ref>
  <a><pmid>PMID23697477   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Henry TM, Smith S, Hicho M. Treat to goal: impact of clinical pharmacist referral service primarily in diabetes management. Hosp Pharm. 2013 Sep;48(8):656-61. doi: 10.1310/hpj4808-656. PubMed PMID: 24421536; PubMed Central PMCID: PMC3847985. 
  </ref>
  <a><pmid>PMID24421536   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Spence MM, Makarem AF, Reyes SL, Rosa LL, Nguyen C, Oyekan EA, Kiyohara AT. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease. J Manag Care Spec Pharm. 2014 Oct;20(10):1036-45. PubMed PMID: 25278326. 
  </ref>
  <a><pmid>PMID25278326   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Upadhyay DK, Mohamed Ibrahim MI, Mishra P, Alurkar VM. A non-clinical
randomised controlled trial to assess the impact of pharmaceutical care
intervention on satisfaction level of newly diagnosed diabetes mellitus patients in a tertiary care teaching hospital in Nepal. BMC Health Serv Res. 2015 Feb
12;15:57. doi: 10.1186/s12913-015-0715-5. 
  </ref>
  <a><pmid>PMID25888828   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Brummel A, Lustig A, Westrich K, Evans MA, Plank GS, Penso J, Dubois RW. Best practices: improving patient outcomes and costs in an ACO through comprehensive
medication therapy management. J Manag Care Spec Pharm. 2014 Dec;20(12):1152-8. 
  </ref>
  <a><pmid>PMID25597053   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chung N, Rascati K, Lopez D, Jokerst J, Garza A. Impact of a clinical pharmacy
program on changes in hemoglobin A1c, diabetes-related hospitalizations, and
diabetes-related emergency department visits for patients with diabetes in an
underserved population. J Manag Care Spec Pharm. 2014 Sep;20(9):914-9. 
  </ref>
  <a><pmid>PMID25166290   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Brophy L, Williams A, Berman EJ, Keleti D, Michael KE, Shepherd M, Fox SA,
Jacobs C, Tan-Torres S, Gelzer AD, Tegenu M. Collaborative DTM reduces
hospitalization and healthcare costs in patients with diabetes treated with
polypharmacy. Am J Manag Care. 2014 Mar 1;20(3):e72-81. 
  </ref>
  <a><pmid>PMID24773329   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sease JM, Franklin MA, Gerrald KR. Pharmacist management of patients with
diabetes mellitus enrolled in a rural free clinic. Am J Health Syst Pharm. 2013
Jan 1;70(1):43-7. doi: 10.2146/ajhp120221. 
  </ref>
  <a><pmid>PMID23261899   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Upadhyay DK, Ibrahim MI, Mishra P, Alurkar VM, Ansari M. Does
pharmacist-supervised intervention through pharmaceutical care program influence direct healthcare cost burden of newly diagnosed diabetics in a tertiary care
teaching hospital in Nepal: a non-clinical randomised controlled trial approach. Daru. 2016 Feb 29;24:6. doi: 10.1186/s40199-016-0145-x. 
  </ref>
  <a><pmid>PMID26926657   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kavalieratos D, Weinberger M, Rao JK. Recommendations of community pharmacists and health food store employees regarding undiagnosed symptoms of diabetes. J Gen Intern Med. 2010 Aug;25(8):799-802. Epub 2010 Apr 2 
  </ref>
  <a><pmid>PMID20361270   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kirwin JL, Cunningham RJ, Sequist TD. Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial. J Manag Care Pharm. 2010 Mar;16(2):104-13 
  </ref>
  <a><pmid>PMID20178395   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Armor BL, Britton ML, Dennis VC, Letassy NA. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010 Jun;23(3):250-64. Epub 2009 May 28. Review 
  </ref>
  <a><pmid>PMID21507822   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     LaMarr B, Valdez C, Driscoll K, Ryan M. Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients. Am J Health Syst Pharm. 2010 Feb 15;67(4):290-4 
  </ref>
  <a><pmid>PMID20133534   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Borges AP, Guidoni CM, Ferreira LD, de Freitas O, Pereira LR. The pharmaceutical care of patients with type 2 diabetes mellitus. Pharm World Sci. 2010 Dec;32(6):730-6. Epub 2010 Aug 24 
  </ref>
  <a><pmid>PMID20734138   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gerber BS, Cano AI, Caceres ML, Smith DE, Wilken LA, Michaud JB, Ruggiero LA, Sharp LK. A pharmacist and health promoter team to improve medication adherence among Latinos with diabetes. Ann Pharmacother. 2010 Jan;44(1):70-9. Epub 2009 Dec 22 
  </ref>
  <a><pmid>PMID20028957   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Granas AG, Berg C, Hjellvik V, Haukereid C, Kronstad A, Blix HS, Kilhovd B, Viktil KK, Horn AM. Evaluating categorisation and clinical relevance of drug-related problems in medication reviews. Pharm World Sci. 2010 Jun;32(3):394-403. Epub 2010 Apr 21 
  </ref>
  <a><pmid>PMID20407926   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Iyer R, Coderre P, McKelvey T, Cooper J, Berger J, Moore E, Kushner M. An employer-based, pharmacist intervention model for patients with type 2 diabetes. Am J Health Syst Pharm. 2010 Feb 15;67(4):312-6. Erratum in: Am J Health Syst Pharm. 2010 Apr 1;67(7):506 
  </ref>
  <a><pmid>PMID20133537   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jameson JP, Baty PJ. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial. Am J Manag Care. 2010 Apr;16(4):250-5 
  </ref>
  <a><pmid>PMID20394460   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Szumita PM. The hospital pharmacist: an integral part of the hyperglycaemic management team. J Clin Pharm Ther. 2009 Dec;34(6):613-21. Review 
  </ref>
  <a><pmid>PMID20175794   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Koenigsfeld CF, Horning KK, Logemann CD, Schmidt GA. Medication therapy management in the primary care setting: a pharmacist-based pay-for-performance project. J Pharm Pract. 2012 Feb;25(1):89-95. Epub 2011 Sep 20. 
  </ref>
  <a><pmid>PMID21933965   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mularski KS, Yeh CP, Bains JK, Mosen DM, Hill AK, Mularski RA. Pharmacist glycemic control team improves quality of glycemic control in surgical patients
with perioperative dysglycemia. Perm J. 2012 Winter;16(1):28-33. 
  </ref>
  <a><pmid>PMID22529756   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Babinec PM, Rock MJ, Lorenzetti DL, Johnson JA. Do researchers use pharmacists' communication as an outcome measure? A scoping review of pharmacist involvement in diabetes care. Int J Pharm Pract. 2010 Aug;18(4):183-93. 
  </ref>
  <a><pmid>PMID20636669   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pepper MJ, Mallory N, Coker TN, Chaki A, Sando KR. Pharmacists' impact on improving outcomes in patients with type 2 diabetes mellitus. Diabetes Educ. 2012 May-Jun;38(3):409-16. doi: 10.1177/0145721712443291. 
  </ref>
  <a><pmid>PMID22523190   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Brennan TA, Dollear TJ, Hu M, Matlin OS, Shrank WH, Choudhry NK, Grambley W. An integrated pharmacy-based program improved medication prescription and adherence rates in diabetes patients. Health Aff (Millwood). 2012 Jan;31(1):120-9. 
  </ref>
  <a><pmid>PMID22232102   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fanous AM, Kier KL, Rush MJ, Terrell S. Impact of a 12-week, pharmacist-directed walking program in an established employee preventive care clinic. Am J Health Syst Pharm. 2014 Jul 15;71(14):1219-25. doi: 10.2146/ajhp130484. PubMed PMID: 24973382 
  </ref>
  <a><pmid>PMID24973382   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Castejón AM, Calderón JL, Perez A, Millar C, McLaughlin-Middlekauff J, Sangasubana N, Alvarez G, Arce L, Hardigan P, Rabionet SE. A community-based pilot study of a diabetes pharmacist intervention in Latinos: impact on weight and hemoglobin A1c. J Health Care Poor Underserved. 2013 Nov;24(4 Suppl):48-60. doi: 10.1353/hpu.2014.0003. PubMed PMID: 24241260. 
  </ref>
  <a><pmid>PMID24241260   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Harris SB, Gerstein HC, Yale JF, Berard L, Stewart J, Webster-Bogaert S, Tompkins JW. Can community retail pharmacist and diabetes expert support facilitate insulin initiation by family physicians? Results of the AIM@GP randomized controlled trial. BMC Health Serv Res. 2013 Feb 21;13:71. doi: 10.1186/1472-6963-13-71. PubMed PMID: 23433347; PubMed Central PMCID: PMC3585701. 
  </ref>
  <a><pmid>PMID23433347   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ip EJ, Shah BM, Yu J, Chan J, Nguyen LT, Bhatt DC. Enhancing diabetes care by adding a pharmacist to the primary care team. Am J Health Syst Pharm. 2013 May 15;70(10):877-86. doi: 10.2146/ajhp120238. PubMed PMID: 23640349. 
  </ref>
  <a><pmid>PMID23640349   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Yu J, Shah BM, Ip EJ, Chan J. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California. J Manag Care Pharm. 2013 Mar;19(2):102-14. PubMed PMID: 23461426. 
  </ref>
  <a><pmid>PMID23461426   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lim PC, Lim K, Embee ZC, Hassali MA, Thiagarajan A, Khan TM. Study
investigating the impact of pharmacist involvement on the outcomes of diabetes
medication therapy adherence program Malaysia. Pak J Pharm Sci. 2016
Mar;29(2):595-601. 
  </ref>
  <a><pmid>PMID27087103   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol. 2009 May;67(5):547-57. Epub 2009 Feb 11
PMID: 19552750; PubMed Central PMCID: PMC2686072. 
  </ref>
  <a><pmid>PMID19552750   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     McFarland MS, Cross LB, Gross B, Gentry C, Tunney J, Patel UP. Drug use evaluation of sitagliptin dosing by pharmacist versus nonpharmacist clinicians in an internal medicine department of a private physician-owned multispecialty clinic. J Manag Care Pharm. 2009 Sep;15(7):563-7 
  </ref>
  <a><pmid>PMID19739879   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Choe HM, Bernstein SJ, Mueller BA, Walker PC, Stevenson JG, Standiford CJ. Pharmacist leads primary care team to improve diabetes care. Am J Health Syst Pharm. 2009 Apr 1;66(7):622-4 
  </ref>
  <a><pmid>PMID19299368   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Davidson MB. Detailed treatment algorithms for effective nurse- and pharmacist-directed diabetes care: a personal approach. Diabetes Educ. 2009 Jan-Feb;35(1):61-71 
  </ref>
  <a><pmid>PMID19244563   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fera T, Bluml BM, Ellis WM. Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc (2003). 2009 May-Jun;49(3):383-91 
  </ref>
  <a><pmid>PMID19357068   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Taveira TH, Friedmann PD, Cohen LB, Dooley AG, Khatana SA, Pirraglia PA, Wu WC. Pharmacist-led group medical appointment model in type 2 diabetes. Diabetes Educ. 2010 Jan-Feb;36(1):109-17. Epub 2009 Dec 4 
  </ref>
  <a><pmid>PMID19966072   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Turnacilar M, Sancar M, Apikoglu-Rabus S, Hursitoglu M, Izzettin FV. Improvement of diabetes indices of care by a short pharmaceutical care program. Pharm World Sci. 2009 Dec;31(6):689-95. 
  </ref>
  <a><pmid>PMID19777365   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Doucette WR, Witry MJ, Farris KB, McDonough RP. Community pharmacist-provided extended diabetes care. Ann Pharmacother. 2009 May;43(5):882-9. doi: 10.1345/aph.1L605. Epub 2009 Apr 28. 
  </ref>
  <a><pmid>PMID19401477   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Yoder VG, Dixon DL, Barnette DJ, Beardsley JR. Short-term outcomes of an employer-sponsored diabetes management program at an ambulatory care pharmacy clinic. Am J Health Syst Pharm. 2012 Jan 1;69(1):69-73. 
  </ref>
  <a><pmid>PMID22180556   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chan CW, Siu SC, Wong CK, Lee VW. A pharmacist care program: positive impact on cardiac risk in patients with type 2 diabetes. J Cardiovasc Pharmacol Ther. 2012 Mar;17(1):57-64. 
  </ref>
  <a><pmid>PMID21335480   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ali M, Schifano F, Robinson P, Phillips G, Doherty L, Melnick P, Laming L, Sinclair A, Dhillon S. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study. Diabet Med. 2012 Sep;29(9):e326-33. 
  </ref>
  <a><pmid>PMID22672148   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev. 2013 Feb 28;2:CD010398. doi: 10.1002/14651858.CD010398. Review. PubMed PMID: 23450614 
  </ref>
  <a><pmid>PMID23450614   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Nishita C, Cardazone G, Uehara DL, Tom T. Empowered diabetes management: life coaching and pharmacist counseling for employed adults with diabetes. Health Educ Behav. 2013 Oct;40(5):581-91. doi: 10.1177/1090198112465088. Epub 2012 Nov 21. PubMed PMID: 23174629. 
  </ref>
  <a><pmid>PMID23174629   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Odegard PS, Carpinito G, Christensen DB. Medication adherence program: adherence challenges and interventions in type 2 diabetes. J Am Pharm Assoc (2003). 2013 May-Jun;53(3):267-72. doi: 10.1331/JAPhA.2013.12065. PubMed PMID: 23699675. 
  </ref>
  <a><pmid>PMID23699675   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pinto SL, Kumar J, Partha G, Bechtol RA. Pharmacist-provided medication therapy management (MTM) program impacts outcomes for employees with diabetes. Popul Health Manag. 2014 Feb;17(1):21-7. doi: 10.1089/pop.2012.0124. Epub 2013 Jul 12. PubMed PMID: 23848476. 
  </ref>
  <a><pmid>PMID23848476   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ploylearmsang C, Sookaneknun P, Poophalee T, Pongruea P. Diabetes and hypertension screening by pharmacy students in Thai communities. Am J Pharm Educ. 2013 Apr 12;77(3):56. doi: 10.5688/ajpe77356. PubMed PMID: 23610474; PubMed Central PMCID: PMC3631731. 
  </ref>
  <a><pmid>PMID23610474   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Obreli-Neto PR, Marusic S, Guidoni CM, Baldoni Ade O, Renovato RD, Pilger D,
Cuman RK, Pereira LR. Economic evaluation of a pharmaceutical care program for
elderly diabetic and hypertensive patients in primary health care: a 36-month
randomized controlled clinical trial. J Manag Care Spec Pharm. 2015
Jan;21(1):66-75. 
  </ref>
  <a><pmid>PMID25562774   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008 Apr;28(4):421-36. Review 
  </ref>
  <a><pmid>PMID18363526   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Padmaja Kumari R, Raman R, Sharma T. Physicians, pharmacists, and people with diabetes in India. Pharm World Sci. 2008 Dec;30(6):750-2. Epub 2008 Jun 13 
  </ref>
  <a><pmid>PMID18548331   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mehuys E, De Bolle L, Van Bortel L, Annemans L, Van Tongelen I, Remon JP, Giri M. Medication use and disease management of type 2 diabetes in Belgium. Pharm World Sci. 2008 Jan;30(1):51-6. Epub 2007 Jun 23 
  </ref>
  <a><pmid>PMID17588213   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fera T, Bluml BM, Ellis WM, Schaller CW, Garrett DG. The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program. J Am Pharm Assoc (2003). 2008 Mar-Apr;48(2):181-90 
  </ref>
  <a><pmid>PMID18359731   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Phumipamorn S, Pongwecharak J, Soorapan S, Pattharachayakul S. Effects of the pharmacist's input on glycaemic control and cardiovascular risks in Muslim diabetes. Prim Care Diabetes. 2008 Feb;2(1):31-7. doi: 10.1016/j.pcd.2007.12.001. Epub 2008 Jan 25 
  </ref>
  <a><pmid>PMID18684418   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Anaya JP, Rivera JO, Lawson K, Garcia J, Luna J Jr, Ortiz M. Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement. Am J Health Syst Pharm. 2008 Oct 1;65(19):1841-5 
  </ref>
  <a><pmid>PMID18796426   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Elnour AA, El Mugammar IT, Jaber T, Revel T, McElnay JC. Pharmaceutical care of patients with gestational diabetes mellitus. J Eval Clin Pract. 2008 Feb;14(1):131-40. 
  </ref>
  <a><pmid>PMID18211656   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Brummel AR, Soliman AM, Carlson AM, de Oliveira DR. Optimal diabetes care outcomes following face-to-face medication therapy management services. Popul Health Manag. 2013 Feb;16(1):28-34. doi: 10.1089/pop.2012.0023. Epub 2012 Oct 31. 
  </ref>
  <a><pmid>PMID23113628   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fox D, Ried LD, Klein GE, Myers W, Foli K. A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes. J Am Pharm Assoc (2003). 2009
Mar-Apr;49(2):192-9. 
  </ref>
  <a><pmid>PMID19289345   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chisholm-Burns MA, Graff Zivin JS, Lee JK, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, Abraham I, Palmer J. Economic effects of pharmacists on health outcomes in the United States: A systematic review. Am J Health Syst Pharm. 2010  Oct 1;67(19):1624-34. doi: 10.2146/ajhp100077. Review. PubMed PMID: 20852164. 
  </ref>
  <a><pmid>PMID20852164   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lowey A, Moore S, Norris C, Wright D, Silcock J, Hammond P. The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes. Pharm World Sci. 2007 Oct;29(5):541-5. Epub 2007 Mar 30 
  </ref>
  <a><pmid>PMID17394096   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions - Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007 Oct;41(10):1569-82. 
  </ref>
  <a><pmid>PMID17712043   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, Lau P, Peterson G, Stewart K, Taylor S, Wilkinson J. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med. 2007 Jun;24(6):677-83. 
  </ref>
  <a><pmid>PMID17523968   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     McKinnon PS, Seaton T, Noirot LA, Reichley RM, Heard KM, Shannon WD, Goldberg AC, Dunagan WC, Bailey TC. Improving adherence to dyslipidemia medication guidelines in hospitalized diabetic patients using a technology-assisted pharmacist intervention. AMIA Annu Symp Proc. 2008 Nov 6:868. 
  </ref>
  <a><pmid>PMID18999065   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Oyetayo OO, James C, Martinez A, Roberson K, Talbert RL. The Hispanic Diabetes Management Program: Impact of community pharmacists on clinical outcomes. J Am Pharm Assoc (2003). 2011 Sep-Oct;51(5):623-6. 
  </ref>
  <a><pmid>PMID21896461   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Taveira TH, Wu WC. Interventions to maintain cardiac risk control after discharge from a cardiovascular risk reduction clinic: a randomized controlled trial. Diabetes Res Clin Pract. 2014 Sep;105(3):327-35. doi: 10.1016/j.diabres.2014.05.013. Epub 2014 Jun 10. PubMed PMID: 24969964. 
  </ref>
  <a><pmid>PMID24969964   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kocarnik BM, Liu CF, Wong ES, Perkins M, Maciejewski ML, Yano EM, Au DH, Piette JD, Bryson CL. Does the presence of a pharmacist in primary care clinics improve diabetes medication adherence? . BMC Health Serv Res. 2012 Nov 13;12:391. doi: 10.1186/1472-6963-12-391. 
  </ref>
  <a><pmid>PMID23148570   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Borges AP, Guidoni CM, Freitas Od, Pereira LR. Economic evaluation of
outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care
service. Arq Bras Endocrinol Metabol. 2011 Dec;55(9):686-91. 
  </ref>
  <a><pmid>PMID22231970   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Worley MM. Testing a pharmacist-patient relationship quality model among older persons with diabetes. Res Social Adm Pharm. 2006 Mar;2(1):1-21 
  </ref>
  <a><pmid>PMID17138498   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Scott DM, Boyd ST, Stephan M, Augustine SC, Reardon TP. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health Syst Pharm. 2006 Nov 1;63(21):2116-22 
  </ref>
  <a><pmid>PMID17057049   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a pilot study. J Clin Pharm Ther. 2006 Aug;31(4):335-41. 
  </ref>
  <a><pmid>PMID16882102   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fornos JA, Andrés NF, Andrés JC, Guerra MM, Egea B. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. Pharm World Sci. 2006 Apr;28(2):65-72. Epub 2006 Jun 22. 
  </ref>
  <a><pmid>PMID16791717   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Irons BK, Seifert CF, Horton NA. Quality of care of a pharmacist-managed diabetes service compared to usual care in an indigent clinic. Diabetes Technol Ther. 2008 Jun;10(3):220-6. 
  </ref>
  <a><pmid>PMID18473697   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, Owens DK. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA. 2006 Jul 26;296(4):427-40. Review. PubMed PMID: 16868301. 
  </ref>
  <a><pmid>PMID16868301   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sarkadi A, Vég A, Rosenqvist U. The influence of participant's self-perceived role on metabolic outcomes in a diabetes group education program. Patient Educ Couns. 2005 Aug;58(2):137-45 
  </ref>
  <a><pmid>PMID16009289   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care. 2005 Apr;11(4):253-60. 
  </ref>
  <a><pmid>PMID15839185   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Clifford RM, Davis WA, Batty KT, Davis TM; Fremantle Diabetes Study. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005 Apr;28(4):771-6. 
  </ref>
  <a><pmid>PMID15793171   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005 Mar;39(3):433-40. Epub 2005 Feb 8. 
  </ref>
  <a><pmid>PMID15701763   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Krass I, Taylor SJ, Smith C, Armour CL. Impact on medication use and adherence of Australian pharmacists' diabetes care services. J Am Pharm Assoc (2003). 2005 Jan-Feb;45(1):33-40. 
  </ref>
  <a><pmid>PMID15730115   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Horning KK, Hoehns JD, Doucette WR. Adherence to clinical practice guidelines for 7 chronic conditions in long-term-care patients who received pharmacist disease management services versus traditional drug regimen review. J Manag Care Pharm. 2007 Jan-Feb;13(1):28-36. 
  </ref>
  <a><pmid>PMID17269834   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mino-León D, Reyes-Morales H, Flores-Hernández S. Effectiveness of involving
pharmacists in the process of ambulatory health care to improve drug treatment
adherence and disease control. J Eval Clin Pract. 2015 Feb;21(1):7-12. doi:
10.1111/jep.12207. Epub 2014 Jun 21. 
  </ref>
  <a><pmid>PMID24953287   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Simpson SH, Johnson JA, Biggs RS, Tsuyuki RT; SCRIP Investigators. Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Pharmacotherapy. 2004 Mar;24(3):389-94 
  </ref>
  <a><pmid>PMID15040652   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Suppapitiporn S, Chindavijak B, Onsanit S. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial. J Med Assoc Thai. 2005 Sep;88 Suppl 4:S134-41. 
  </ref>
  <a><pmid>PMID16623018   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Worley MM, Hermansen-Kobulnicky CJ. Outcome and self-efficacy expectations for medication management of patients with diabetes: influence of the pharmacist-patient relationship. J Am Pharm Assoc (2003). 2008Sep-Oct;48(5):621-31. 
  </ref>
  <a><pmid>PMID18826901   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Cioffi ST, Caron MF, Kalus JS, Hill P, Buckley TE. Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic. Ann Pharmacother. 2004 May;38(5):771-5. Epub 2004 Mar 18. 
  </ref>
  <a><pmid>PMID15031417   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     John EJ, Vavra T, Farris K, Currie J, Doucette W, Button-Neumann B, Osterhaus M, Kumbera P, Halterman T, Bullock T. Workplace-based cardiovascular risk management by community pharmacists: impact on blood pressure, lipid levels, and weight. Pharmacotherapy. 2006 Oct;26(10):1511-7. 
  </ref>
  <a><pmid>PMID16999661   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jiménez-Ramírez F, Pérez R. Diabetic retinopathy education and screening at
the community pharmacy in Puerto Rico. P R Health Sci J. 2011 Sep;30(3):139-44. 
  </ref>
  <a><pmid>PMID21932716   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rothman RL, DeWalt DA, Malone R, Bryant B, Shintani A, Crigler B, Weinberger M, Pignone M. Influence of patient literacy on the effectiveness of a primary care-based diabetes disease management program. JAMA. 2004 Oct 13;292(14):1711-6. 
  </ref>
  <a><pmid>PMID15479936   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rothman RL, Malone R, Bryant B, Shintani AK, Crigler B, Dewalt DA, Dittus RS, Weinberger M, Pignone MP. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med. 2005 Mar;118(3):276-84. 
  </ref>
  <a><pmid>PMID15745726   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rothman RL, So SA, Shin J, Malone RM, Bryant B, Dewalt DA, Pignone MP, Dittus RS. Labor characteristics and program costs of a successful diabetes disease management program. Am J Manag Care. 2006 May;12(5):277-83. 
  </ref>
  <a><pmid>PMID16686585   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jacobs M, Sherry PS, Taylor LM, Amato M, Tataronis GR, Cushing G. Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED) study. J Am Pharm Assoc (2003). 2012 Sep-Oct;52(5):613-21. 
  </ref>
  <a><pmid>PMID23023841   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Haggerty SA, Cerulli J, Zeolla MM, Cottrell JS, Weck MB, Faragon JJ. Community pharmacy Target Intervention Program to improve aspirin use in persons with diabetes. J Am Pharm Assoc (2003). 2005 Jan-Feb;45(1):17-22. 
  </ref>
  <a><pmid>PMID15730113   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2000 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Irons BK, Lenz RJ, Anderson SL, Wharton BL, Habeger B, Anderson HG Jr. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy. 2002 Oct;22(10):1294-300. 
  </ref>
  <a><pmid>PMID12389879   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2000 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Yanchick JK. Implementation of a drug therapy monitoring clinic in a primary-care setting. Am J Health Syst Pharm. 2000 Dec 15;57 Suppl 4:S30-4 
  </ref>
  <a><pmid>PMID11148942   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Davidson MB, Karlan VJ, Hair TL. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual. 2000 Jul-Aug;15(4):137-42. 
  </ref>
  <a><pmid>PMID10948785   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1996 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Berringer R, Shibley MC, Cary CC, Pugh CB, Powers PA, Rafi JA. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc (Wash). 1999 Nov-Dec;39(6):791-7 
  </ref>
  <a><pmid>PMID10609444   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1996 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother. 1996 Mar;30(3):238-43. 
  </ref>
  <a><pmid>PMID8833557   </pmid></a> 
</dd> 
</dl>